Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Mallinckrodt
Argus Health
Daiichi Sankyo
Accenture
US Department of Justice
Harvard Business School
UBS
Fish and Richardson

Generated: November 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021247

« Back to Dashboard

NDA 021247 describes AEROSPAN HFA, which is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. Additional details are available on the AEROSPAN HFA profile page.

The generic ingredient in AEROSPAN HFA is flunisolide. There are twelve drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the flunisolide profile page.
Summary for 021247
Tradename:AEROSPAN HFA
Applicant:Mylan Speciality Lp
Ingredient:flunisolide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 021247
Suppliers and Packaging for NDA: 021247
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AEROSPAN HFA flunisolide AEROSOL, METERED;INHALATION 021247 NDA Meda Pharmaceuticals 0037-7590 0037-7590-12 1 INHALER in 1 CARTON (0037-7590-12) > 120 AEROSOL, METERED in 1 INHALER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;INHALATIONStrength0.078MG/INH
Approval Date:Jan 27, 2006TE:RLD:Yes

Expired US Patents for NDA 021247

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp AEROSPAN HFA flunisolide AEROSOL, METERED;INHALATION 021247-001 Jan 27, 2006 ➤ Sign Up ➤ Sign Up
Mylan Speciality Lp AEROSPAN HFA flunisolide AEROSOL, METERED;INHALATION 021247-001 Jan 27, 2006 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Cipla
Dow
Daiichi Sankyo
Cantor Fitzgerald
Express Scripts
Deloitte
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.